FDA Investigator Norman K Starks
Norman K Starks has inspections in 2 countries as of 29 Sep 2023. Norman K Starks has collaborated with a combined 3414 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
40
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Israel
Co-Investigator(s):
Alan M Roberts,
Alicia M Mozzachio,
Ana L Kewes,
Anders W Evenson,
Anthony J Ladner,
Ashley L Reiber,
Barbara J Holladay,
Barbara Janine Breithaupt,
Brett R Havranek,
Brian D Nicholson,
Bruce H Mccullough,
Bruce M Mccullough,
Bryan L Mcguckin,
Bryce H Thompson,
Byungja E Marciante,
Carl A Huffman, III,
Carrie Ann Plucinski,
Cassandra L Abellard,
Chad J Whitwell,
Chaltu N Wakijra,
Charles L Zhou,
Charles R Bonapace, PhD,
Charles R Cole,
Charles R Cote, RIC,
Chilton L Ng,
Christian D Lynch (CDL),
Christina A Miller,
Christina K Theodorou,
Christine M Smith,
Christine Mwhitby Smith,
Christopher D Leach,
Concepcion Cruz, Jr,
Constantin Y Philopoulos,
Courtney E Hillier,
Cynthia A Harris, MD, RN,
Cynthia J Lee, MS,
Cynthia Jim, CSO,
Cynthia M Goudeau,
Dacia E Quick,
Dale A Nyberg,
Daniel R Azar,
Dariusz Galezowski,
David Perkins,
Debra Bower,
Debra I Love,
Denarvis C Mendenhall,
Dennis L Doupnik,
Derek S Smith, PhD,
Dewayne E Whitlock,
Deyaa Shaheen,
Donna K Speer,
Douglas A Campbell,
Douglas R Nelson,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Emest F Bizjak,
Emmanuel A Dimaano, Jr,
Enrico Joset Mangahis,
Eric M Mueller, PharmD,
Erika V Butler,
Erin L Mcfiren,
Gerald E Scholze,
Gloria J Champagne,
Greg Brinsley,
Gregory R Brinsley,
Gwyn G Dickinson,
Ingrid Y Johnson,
Jacqueline Mdiaz Albertini,
James P Duggan,
James P Mcreavey,
James W Plucinski,
Janet B Abt,
Jeanne M Morris,
Jesse P Romenesko,
Jessica D Nanini,
Joohi Castelvetere,
Jose Alopez Rubet,
Jose R Hernandez,
Joseph R Lambert,
Joshua M Adams,
Julie D Bringger,
Justin A Boyd,
Jyoti B Patel, PhD,
Katherine E Jacobitz,
Kathleen S Tormey,
Kenneth A Libertoski,
Kenneth Nieves,
Kerry L Edwards, III,
Kevin P Regan,
Kurt A Brorson, PhD,
Lakisha M Williams,
Lata C Mathew, PhD,
Laura A Adam,
Leonard H Lavi,
Lequita M Mayhew,
Lindsey S Fleischman,
Lisa Hayka,
Lisa Hornback,
Lisa L Flores,
Loan Chin,
Logan M Ebeling,
Luis M Burgos,
Luis M Burgos Medero,
Lynette P Salisbury,
Maksim A Levenchuk,
Marcia A Worley,
Marcus A Ray,
Margaret M Annes,
Marie Bbuen Bigornia,
Mark G Peterson,
Mary G Leadbetter,
Matthew M Schuckmann,
Michael A Charles,
Michael D Smedley,
Michael F Skelly, PhD,
Michael S Araneta,
Michael S Kopf,
Michael Y Philopoulos,
Michele L Glendenning,
Michele Perry Williams,
Michelle L Dragon,
Monica E Murie,
Monica M Mcclure,
Muna Algharibeh,
Nebil A Oumer,
Nibin Varghese, MS,
Nicholas F Lyons,
Nicholas P Diorio,
Nicholas Z Lu,
Pablo Alcantara,
Paola E Lathrop,
Patricia A Mcilroy,
Patrick J Campbell,
Paula J Bretz,
Paula P Demichael,
Peng Zhou,
Philip J Snoy,
Pratik S Upadhyay, DDC,
Rachel C Harrington,
Rachel T Evans,
Rafael Padilla,
Rebecca L Mullikin,
Richard Heath Coats,
Rita K Kabaso,
Robert D Tollefsen,
Robert J Doyle,
Robert J Ham,
Robert L Hummel,
Rose M Ashley,
Russell K Riley,
Samuel A Hamblin,
Sandra A Boyd,
Sandra A Hughes,
Shafiq S Ahadi,
Sharon K Thoma, PharmD,
Sherry G Bous,
Simone E Pitts,
Soyinka S Eneng,
State Agency,
Stefen D Mcmillan,
Stephanie L Shapley,
Steven D Kehoe,
Steven P Donald,
Sullan,
Susan D Yuscius,
Susan M Jackson,
Susan P Bruederle,
Tamara Brey,
Tara L Breckenridge,
Tara L Greene,
Tarsha T Mcclendon,
That Q Dang,
Theresa C Klaman,
Thomas J Arista,
Timothy S Roddy,
Todd Q Dang,
Toyin B Oladimeji,
Vioela J Caze,
Walden H Lee,
Warren J Lopicka,
Wayne T Smith,
William A Warnick,
William D Sherman,
Yvesna C Blaise,
Yvonne E Lozano,
Zachary L Miller,
Zhongren Wu
Norman K Starks's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more